Literature DB >> 6182426

Postmenopausal spinal osteoporosis: physical therapy and rehabilitation principles.

M Sinaki.   

Abstract

In this communication the physical therapy and rehabilitation measures utilized in the management of patients with spinal osteoporosis are discussed. The bone loss and the subsequent bone disease that occur in some older persons, and especially in postmenopausal women, call for special physical therapeutic measures. One should be cautious about prescribing exercises, for some may predispose the spine to undue sprain and strain. This principle applies to any exercise program, whether therapeutic or recreational.

Entities:  

Mesh:

Year:  1982        PMID: 6182426

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

Review 1.  Current knowledge about physiotherapeutic strategies in osteoporosis prevention and treatment.

Authors:  U Lange; J Teichmann; C Uhlemann
Journal:  Rheumatol Int       Date:  2004-11-27       Impact factor: 2.631

2.  The role of physical exercise in prevention and management of osteoporosis.

Authors:  G Dilşen; C Berker; A Oral; G Varan
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

Review 3.  The role of exercise in the treatment of osteoporosis.

Authors:  Mehrsheed Sinaki; Michael Pfeifer; Elisabeth Preisinger; Eiji Itoi; René Rizzoli; Steven Boonen; Piet Geusens; Helmut W Minne
Journal:  Curr Osteoporos Rep       Date:  2010-09       Impact factor: 5.096

4.  Effect of low-intensity back exercise on quality of life and back extensor strength in patients with osteoporosis: a randomized controlled trial.

Authors:  M Hongo; E Itoi; M Sinaki; N Miyakoshi; Y Shimada; S Maekawa; K Okada; Y Mizutani
Journal:  Osteoporos Int       Date:  2007-06-16       Impact factor: 4.507

5.  Spinal extension exercises prevent natural progression of kyphosis.

Authors:  J M Ball; P Cagle; B E Johnson; C Lucasey; B P Lukert
Journal:  Osteoporos Int       Date:  2008-07-26       Impact factor: 4.507

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.